glp-1 and gip/glp-1 medications GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GLP-1s for Weight Loss: What
Description
But we don't have clean human data on that arc yet
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
While they do mention that licensed medical providers will do the prescribing, there are no names, credentials, or board certifications listed
Post-surgery, Gantt required an ileostomy bag to collect waste from her body

Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity

Liraglutide also carries warnings about pancreatitis, liraglutide pen sharing, hypoglycemia when used in conjunction with certain other drugs known to cause hypoglycemia including insulin and sulfonylurea, renal impairment or kidney failure, hypersensitivity and acute gallbladder disease
GLP-1s impact digestion, vagal tone, appetite signaling, bowel motility, and cardiometabolic markers, and they interact with stress physiology and immune activation in ways that can either support or destabilize clients already navigating complex chronic conditions
